GLP-1 Receptor Pathway Research In laboratory research models, semaglutide peptide acts as a selective GLP-1 receptor agonist
Blood testing is sometimes conducted but less common
A systematic review Publisher's note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
And were always looking for new material, new questions
You should contact your GP if you experience: Unilateral (one-sided) breast swelling or a hard, irregular lump Nipple discharge, skin changes, or nipple inversion Rapidly progressive breast enlargement Associated symptoms such as testicular pain or swelling Breast changes alongside unexplained weight loss or fatigue In line with NICE guideline NG12 (Suspected Cancer: Recognition and Referral), GPs should consider an urgent two-week wait referral to a breast clinic for any male with a unilateral, firm, subareolar mass with or without nipple discharge, or any other breast presentation that raises clinical concern irrespective of age
However, the patients remained stable for 12 months after stopping drug treatment
